These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30766109)

  • 1. New Treatments for Hepatitis C.
    Ho SB; Ma A; Smith JP
    Fed Pract; 2015 Feb; 32(Suppl 2):25S-31S. PubMed ID: 30766109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.
    Kurokawa K; Ohki T; Kato J; Fukumura Y; Imai M; Shibata C; Arai J; Kondo M; Takagi K; Kojima K; Seki M; Mori M; Toda N; Tagawa K
    J Med Case Rep; 2020 May; 14(1):62. PubMed ID: 32456712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained virologic response by direct-acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection.
    Endo K; Sato T; Suzuki A; Yoshida Y; Kakisaka K; Miyasaka A; Takikawa Y
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1602-1609. PubMed ID: 31975438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C.
    Enomoto M; Ikura Y; Tamori A; Kozuka R; Motoyama H; Kawamura E; Hagihara A; Fujii H; Uchida-Kobayashi S; Morikawa H; Murakami Y; Kawada N
    United European Gastroenterol J; 2018 Nov; 6(9):1391-1400. PubMed ID: 30386612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUSTAINED VIROLOGIC RESPONSE RATE IN CHRONIC HEPATITIS C PATIENTS THROUGH DIRECT-ACTING ANTIVIRALS THERAPY.
    Torres AD; Sparvoli JMH; Sparvoli AC; Gonçalves CV
    Arq Gastroenterol; 2019; 56(4):394-398. PubMed ID: 31800735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration.
    Fox DS; McGinnis JJ; Tonnu-Mihara IQ; McCombs JS
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1136-1142. PubMed ID: 27869323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients.
    Ting PS; Hamilton JP; Gurakar A; Urrunaga NH; Ma M; Glorioso J; King E; Toman LP; Wesson R; Garonzik-Wang J; Ottmann S; Philosophe B; Sulkowski M; Cameron AM; Durand CM; Chen PH
    Transpl Infect Dis; 2019 Dec; 21(6):e13194. PubMed ID: 31609520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy
.
    Ghosn M; Palmer MB; Najem CE; Haddad D; Merkel PA; Hogan JJ
    Clin Nephrol; 2017 May; 87 (2017)(5):261-266. PubMed ID: 28332476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials.
    Ferreira VL; Tonin FS; Assis Jarek NA; Ramires Y; Pontarolo R
    Clin Drug Investig; 2017 Jul; 37(7):635-646. PubMed ID: 28409482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Direct-Acting Antiviral Therapy for Renal Function in Post-Kidney Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response: A Single-Center Study.
    Kawagishi N; Nakamura A; Takayama T; Haga I
    Ther Apher Dial; 2020 Apr; 24(2):184-188. PubMed ID: 31290282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.
    Kwo PY; Puenpatom A; Zhang Z; Hui SL; Kelley AA; Muschi D
    PLoS One; 2019; 14(8):e0218759. PubMed ID: 31437170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients.
    Owusu Sekyere S; Port K; Deterding K; Cornberg M; Wedemeyer H
    United European Gastroenterol J; 2021 May; 9(4):486-496. PubMed ID: 33349201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C.
    Falcão F; Lopes C; Viegas E; Perez R; Aldir I; Farinha H; Carvalho A; Mirco A; Marques S; Bana E Costa T; Miranda AC; Lebre L; Peixe P; Chagas C; Mansinho K; Correia JM
    Acta Med Port; 2019 Mar; 32(3):189-194. PubMed ID: 30946789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of baseline resistance-associated substitutions on the efficiency of glecaprevir/pibrentasvir in chronic hepatitis C subjects: A meta-analysis.
    Zhang Y; Jiang X; Zhao Y; Xu Y
    J Viral Hepat; 2021 Jan; 28(1):177-185. PubMed ID: 32961624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
    García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
    Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Post-Liver Transplant Hepatic Dysfunction After Sustained Virologic Response Following Direct-Acting Anti-Hepatitis C Therapy.
    Jain A; Riley TR; Krok KL; Schreibman I; Karamchandani DM; Liao X; Tian Y; Dohi T; Kadry Z
    Exp Clin Transplant; 2020 Jun; 18(3):345-352. PubMed ID: 30295586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 25-Vitamin D levels in chronic hepatitis C infection: association with cirrhosis and sustained virologic response.
    Backstedt D; Pedersen M; Choi M; Seetharam A
    Ann Gastroenterol; 2017; 30(3):344-348. PubMed ID: 28469365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents.
    Mashaal AR; Abd El-Hameed M; El Ray AA; Mahmoud Diab T; Dawood RM; Shemis MA; Seyam M
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):2965-2971. PubMed ID: 36172658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges.
    Baumert TF; Berg T; Lim JK; Nelson DR
    Gastroenterology; 2019 Jan; 156(2):431-445. PubMed ID: 30342035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil.
    Ferreira VL; Borba HHL; Wiens A; Pedroso MLA; Radunz VFC; Ivantes CAP; Kuniyoshi ASO; Pontarolo R
    Braz J Infect Dis; 2018; 22(3):186-192. PubMed ID: 29752891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.